Inotiv, Inc. is a leading contract research organization (CRO) providing nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries. The company also sells research-quality animals (including non-human primates) and diets to pharmaceutical, biotech, academia, and government clients. Inotiv focuses on bringing new drugs and medical devices through discovery and preclinical phases, and in certain cases clinical phases, while improving efficiency and reducing development costs.
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-12-05 | 2025-09-30 | 0001628280-25-055483 | EDGAR | 83K words |
| 2024-12-04 | 2024-09-30 | 0001628280-24-049947 | EDGAR | — |
| 2023-12-12 | 2023-09-30 | 0001628280-23-041266 | EDGAR | — |
| 2023-01-13 | 2022-09-30 | 0001558370-23-000243 | EDGAR | — |
| 2021-12-21 | 2021-09-30 | 0001558370-21-016976 | EDGAR | — |
| 2020-12-22 | 2020-09-30 | 0001104659-20-138651 | EDGAR | — |
| 2019-12-26 | 2019-09-30 | 0001104659-19-076191 | EDGAR | — |
| 2018-12-21 | 2018-09-30 | 0001144204-18-066005 | EDGAR | — |
| 2017-12-22 | 2017-09-30 | 0001144204-17-065076 | EDGAR | — |
| 2016-12-28 | 2016-09-30 | 0001144204-16-141558 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-09 | 2025-12-31 | 0001628280-26-006468 | EDGAR | 35K words |
| 2025-08-07 | 2025-06-30 | 0001628280-25-039017 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001628280-25-023370 | EDGAR | — |
| 2025-02-06 | 2024-12-31 | 0001628280-25-004178 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001628280-24-036297 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001628280-24-023632 | EDGAR | — |
| 2024-02-07 | 2023-12-31 | 0001628280-24-003732 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001628280-23-029076 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001558370-23-009868 | EDGAR | — |
| 2023-02-14 | 2022-12-31 | 0001558370-23-001264 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001558370-22-013530 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001558370-22-008809 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-24 | 0001628280-26-020674 | EDGAR | 1K words |
| 2026-03-10 | 0001628280-26-016241 | EDGAR | — |
| 2026-02-09 | 0001628280-26-006192 | EDGAR | — |
| 2026-01-16 | 0001628280-26-002390 | EDGAR | — |
| 2026-01-07 | 0001628280-26-001160 | EDGAR | — |
| 2025-12-03 | 0001628280-25-055025 | EDGAR | — |
| 2025-11-17 | 0001628280-25-052675 | EDGAR | — |
| 2025-09-25 | 0001628280-25-042837 | EDGAR | — |
| 2025-08-18 | 0001628280-25-040658 | EDGAR | — |
| 2025-08-06 | 0001628280-25-038338 | EDGAR | — |
429 total filings indexed. 397 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000720154 |
| Ticker | NOTV |
| Exchange | Nasdaq |
| SIC | 8731: Services-Commercial Physical & Biological Research |
| Incorporated | IN |
| Headquarters | West Lafayette, Indiana |
| Website | https://www.inotivco.com |
| Listed | 1997-11-25 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report